Toward less futile surgery in non-small cell lung cancer? A randomized clinical trial to evaluate the cost-effectiveness of positron emission tomographyVAN TINTEREN, Harm; HOEKSTRA, Otto S; SMIT, Egbert F et al.Controlled clinical trials. 2001, Vol 22, Num 1, pp 89-98, issn 0197-2456Article

Economic evaluation of three two-drug chemotherapy regimens in advanced non-small-cell lung cancerNEYMARK, Niels; LIANES, Pilar; SMIT, Egbert F et al.PharmacoEconomics (Auckland). 2005, Vol 23, Num 11, pp 1155-1166, issn 1170-7690, 12 p.Article

Retrospective evaluation of thromboembolic events in patients with non-small cell lung cancer treated with platinum-based chemotherapyMELLEMA, Wouter W; VAN DER HOEK, Dorien; POSTMUS, Pieter E et al.Lung cancer. 2014, Vol 86, Num 1, pp 73-77, issn 0169-5002, 5 p.Article

Time and dose-related changes in radiological lung density after concurrent chemoradiotherapy for lung cancerPHERNAMBUCQ, Erik C. J; PALMA, David A; VINCENT, Andrew et al.Lung cancer. 2011, Vol 74, Num 3, pp 451-456, issn 0169-5002, 6 p.Article

Fluorescence bronchoscopy for early detection of lung cancer: A clinical perspectiveSUTEDJA, Tom G; VENMANS, Ben J; SMIT, Egbert F et al.Lung cancer. 2001, Vol 34, Num 2, pp 157-168, issn 0169-5002Article

Baseline quality of life and performance status as prognostic factors in patients with extensive-stage disease small cell lung cancer treated with pemetrexed plus carboplatin vs. etoposide plus carboplatinRECK, Martin; THATCHER, Nick; SMIT, Egbert F et al.Lung cancer. 2012, Vol 78, Num 3, pp 276-281, issn 0169-5002, 6 p.Article

Absolute Quantification of [¹¹C]docetaxel Kinetics in Lung Cancer Patients Using Positron Emission TomographyVAN DER VELDT, Astrid A. M; LUBBERINK, Mark; RIJNDERS, Anneloes Y et al.Clinical cancer research (Print). 2011, Vol 17, Num 14, pp 4814-4824, issn 1078-0432, 11 p.Article

Traditional versus up-front [¹⁸F] fluorodeoxyglucose- positron emission tomography staging of non-small-cell lung cancer : A dutch cooperative randomized studyHERDER, Gerarda J. M; KRAMER, Henk; PAUL, Marinus A et al.Journal of clinical oncology. 2006, Vol 24, Num 12, pp 1800-1806, issn 0732-183X, 7 p.Conference Paper

Elevated hTERT mRNA levels: A potential determinant of bronchial squamous cell carcinoma (in situ)SNIJDERS, Peter J. F; BREUER, Roderick H. J; VAN DER ZEE, Ate G. J et al.International journal of cancer. 2004, Vol 109, Num 3, pp 412-417, issn 0020-7136, 6 p.Article

Methods to monitor response to chemotherapy in non-small cell lung cancer with ¹⁸F-FDG PETHOEKSTRA, Corneline J; HOEKSTRA, Otto S; STROOBANTS, Sigrid G et al.The Journal of nuclear medicine (1978). 2002, Vol 43, Num 10, pp 1304-1309, issn 0161-5505, 6 p.Article

Time for Reappraisal of Extracranial Treatment Options?: Synchronous Brain Metastases From Nonsmall Cell Lung CancerLIND, Joline S. W; LAGERWAARD, Frank J; SMIT, Egbert F et al.Cancer. 2011, Vol 117, Num 3, pp 597-605, issn 0008-543X, 9 p.Article

Oral Nutritional Supplements Containing (n-3) Polyunsaturated Fatty Acids Affect the Nutritional Status of Patients with Stage III Non-Small Cell Lung Cancer during Multimodality TreatmentVAN DER MEIJ, Barbara S; LANGIUS, Jacqueline A. E; SMIT, Egbert F et al.The Journal of nutrition. 2010, Vol 140, Num 10, pp 1774-1780, issn 0022-3166, 7 p.Article

Meta-Analysis of Single-Agent Chemotherapy Compared With Combination Chemotherapy As Second-Line Treatment of Advanced Non-Small-Cell Lung CancerDI MAIO, Massimo; CHIODINI, Paolo; PERRONE, Francesco et al.Journal of clinical oncology. 2009, Vol 27, Num 11, pp 1836-1843, issn 0732-183X, 8 p.Article

Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancerVAN MEERBEECK, Jan P; KRAMER, Gijs W. P. M; SPLINTER, Ted A. W et al.Journal of the National Cancer Institute. 2007, Vol 99, Num 6, pp 442-450, issn 0027-8874, 9 p.Article

Quality assurance of thoracic radiotherapy in EORTC 08941 : A randomised trial of surgery versus thoracic radiotherapy in patients with stage IIA non-small-cell lung cancer (NSCLC) after response to induction chemotherapyKRAMER, Gijsbert W. P. M; LEGRAND, Catherine L; GIACCONE, Giuseppe et al.European journal of cancer (1990). 2006, Vol 42, Num 10, pp 1391-1398, issn 0959-8049, 8 p.Article

European organization for research and treatment of cancer (EORTC) 08957 Phase II study of topotecan in combination with cisplatin as second-line treatment of refractory and sensitive small cell lung cancerARDIZZONI, Andrea; MANEGOLD, Christian; NEUMAIER, Carlo et al.Clinical cancer research. 2003, Vol 9, Num 1, pp 143-150, issn 1078-0432, 8 p.Article

Arginase-1 mRNA expression correlates with myeloid-derived suppressor cell levels in peripheral blood of NSCLC patientsHEUVERS, Marlies E; MUSKENS, Femke; BEZEMER, Koen et al.Lung cancer. 2013, Vol 81, Num 3, pp 468-474, issn 0169-5002, 7 p.Article

Pre-cachexia and cachexia at diagnosis of stage III non-small-cell lung carcinoma: an exploratory study comparing two consensus-based frameworksVAN DER MEIJ, Barbara S; SCHOONBEEK, Coline P; SMIT, Egbert F et al.British journal of nutrition. 2013, Vol 109, Num 12, pp 2231-2239, issn 0007-1145, 9 p.Article

Germline Polymorphisms in Patients With Advanced Nonsmall Cell Lung Cancer Receiving First-Line Platinum-Gemcitabine Chemotherapy: A Prospective Clinical StudyJOERGER, Markus; BURGERS, Sjaak. A; BEIJNEN, Jos H et al.Cancer. 2012, Vol 118, Num 9, pp 2466-2475, issn 0008-543X, 10 p.Article

Deletions of 11q22.3-q25 Are Associated with Atypical Lung Carcinoids and Poor Clinical OutcomeSWARTS, Dorian R. A; CLAESSEN, Sandra M. H; VINK, Aryan et al.The American journal of pathology. 2011, Vol 179, Num 3, pp 1129-1137, issn 0002-9440, 9 p.Article

Randomized Phase II and Pharmacogenetic Study of Pemetrexed Compared With Pemetrexed Plus Carboplatin in Pretreated Patients With Advanced Non-Small-Cell Lung CancerSMIT, Egbert F; BURGERS, Sjaak A; GROEN, Harry J. M et al.Journal of clinical oncology. 2009, Vol 27, Num 12, pp 2038-2045, issn 0732-183X, 8 p.Article

The influence of fluticasone inhalation on markers of carcinogenesis in bronchial epitheliumVAN DEN BERG, Remco M; VAN TINTEREN, Harm; SNIJDERS, Peter J. F et al.American journal of respiratory and critical care medicine. 2007, Vol 175, Num 10, pp 1061-1065, issn 1073-449X, 5 p.Article

Three-arm randomized study of two cisplatin-based regimens and paclitaxel plus Gemcitabine in advanced non-small-cell lung cancer: A phase III trial of the european organization for research and treatment of cancer lung cancer group: EORTC 08975SMIT, Egbert F; VAN MEERBEECK, Jan P. A. M; NEYMARK, Niels et al.Journal of clinical oncology. 2003, Vol 21, Num 21, pp 3909-3917, issn 0732-183X, 9 p.Article

Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trialVAN TINTEREN, Harm; HOEKSTRA, Otto S; VAN MOURIK, Johan C et al.Lancet (British edition). 2002, Vol 359, Num 9315, pp 1388-1392, issn 0140-6736Article

Staging of non-small-cell lung cancer and application of FDG-PET: A cost modeling approachVERBOOM, Paul; HERDER, G. Judith M; HOEKSTRA, Otto S et al.International journal of technology assessment in health care. 2002, Vol 18, Num 3, pp 576-585, issn 0266-4623, 10 p.Article